Merck KGaA MRK StarRatingValueLabel_3Julie Utterback, CFA - Senior Equity Analyst - Morningstar Inc.

Balance Sheet
20192020202120222023
Assets
Current Assets
Cash, cash equivalents, and short-term investments
Cash and cash equivalents541.001,110.001,511.001,398.001,578.00
Short-term investments29.0029.00112.00244.00431.00
Total cash, cash equivalents, and short-term investments570.001,139.001,623.001,642.002,009.00
Accounts receivable3,488.003,221.003,646.004,114.004,004.00
Inventory3,342.003,294.003,900.004,632.004,637.00
Other Current Assets1,603.001,626.001,813.001,813.001,743.00
Total current assets9,003.009,280.0010,982.0012,201.0012,393.00
Non Current Assets
Not property, plant and equipment6,213.006,421.007,217.008,203.009,056.00
Equity and other investments-----
Intangibles26,316.0023,612.0024,616.0025,715.0024,396.00
Deferred Income Taxes1,421.001,543.001,502.001,310.001,514.00
Other Long-Term Assets858.00940.001,045.001,097.001,136.00
Total non-current assets34,808.0032,516.0034,380.0036,325.0036,102.00
Total Assets43,811.0041,796.0045,362.0048,526.0048,495.00
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Accounts Payable2,054.001,768.001,542.001,595.001,770.00
Taxes Payable1,609.001,617.001,647.001,683.001,596.00
Current Debt4,423.002,182.002,379.001,073.00503.00
Other current liabilities3,756.003,664.004,864.005,162.004,830.00
Total current liabilities11,842.009,231.0010,432.009,513.008,699.00
Non-current liabilities
Deferred taxes liabilities1,828.001,441.001,411.001,279.001,130.00
Long Term Debt8,129.009,418.007,928.008,834.008,846.00
Other long-term liabilities-----
Total non-current liabilities-----
Total Liabilities-----
Stockholders' equity
Common stock565.00565.00565.00565.00565.00
Additional paid-in capital3,814.003,814.003,814.003,814.003,814.00
Other reserves-----
Retained earnings11,507.0012,378.0015,134.0018,463.0020,228.00
Minority Interests48.0071.0078.0078.0075.00
Total stockholders' equity17,865.0016,946.0021,338.0025,927.0026,680.00
Total liabilities and stockholders' equity43,811.0041,796.0045,362.0048,526.0048,495.00

Figures in millions. Currency is EUR.

Julie Utterback, CFA - Senior Equity Analyst - Morningstar Inc.
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures